Spectral AI, Inc. (MDAI) intrinsic value & 10-year financials

Spectral AI, Inc. (MDAI) has a Graham intrinsic value of $1.96 per share. At $1.51 on Oct 17, 2026, the stock trades 23% below that value. Over the last 6 fiscal years revenue shrank 8.2% a year to $19.6M, with an average return on invested capital of 52.5%.

Graham intrinsic value
$1.96
Share price (Oct 17, 2026)
$1.51
Price vs Graham value
23% below
Market cap
$40.0M
Revenue (FY2025)
$19.6M
Revenue growth (6-yr CAGR)
-8.2%
ROIC (10-yr avg)
52.5%
Free cash flow (FY2025)
—

MDAI 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $19.6M -$7.6M -$0.29 — -43.8% 67.8%
FY2024 $29.6M -$15.3M -$0.85 — -22.3% 61.2%
FY2023 $18.1M -$20.9M -$1.48 — -71.9% 103.6%
FY2022 $25.4M $11.0M -$0.22 — -4.9% 9.5%
FY2021 — -$2.1M — — — 20.7%
FY2020 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Spectral AI, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Spectral AI, Inc. has earned high returns on invested capital, averaging 52.5% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.

Spectral AI, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Spectral AI, Inc. is modeled at -8.2% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $1.96 per share.

MDAI stock: frequently asked questions

What is the intrinsic value of Spectral AI, Inc. (MDAI) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a -8.2% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, MDAI's intrinsic value is about $1.96 per share.

Is MDAI stock undervalued?

At $1.51 (close on Oct 17, 2026), MDAI trades 23% below its Graham value of $1.96. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

What is MDAI's return on invested capital?

Average ROIC over the last 6 fiscal years was 52.5%, and average return on equity was 142.8%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this MDAI data come from?

From Spectral AI, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 13, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar surgical & medical instruments & apparatus stocks